Perrigo Company plc (LON:0Y5E)

Market Cap	1.47B -45.8%
Revenue (ttm)	3.19B -2.5%
Net Income	-38.63M
EPS	-0.28
Shares Out	n/a
PE Ratio	n/a
Forward PE	5.60
Dividend	0.87 (6.13%)
Ex-Dividend Date	Nov 28, 2025

Volume	23
Average Volume	1,001
Open	14.67
Previous Close	14.45
Day's Range	14.24 - 14.67
52-Week Range	12.18 - 30.81
Beta	0.40
RSI	52.02
Earnings Date	Feb 27, 2026

About Perrigo Company

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain rel...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1887
• Employees: 8,379
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Y5E

Financial Performance

In 2024, Perrigo Company's revenue was $4.37 billion, a decrease of -6.06% compared to the previous year's $4.66 billion. Losses were -$171.80 million, 1252.8% more than in 2023.

Financial numbers in USD